CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Planned sale President & CEO sold 7,500 shares at $6.01 ($45,075)
- 4 Planned sale Chief Development Officer sold 49,564 shares at $6.92 ($342,983)
- 4 Planned sale President & CEO sold 3,000 shares at $6.07 ($18,210)
- 4 Open-market sale Chief Development Officer sold 5,312 shares at $6.26 ($33,254)
- 4 Open-market sale President & CEO sold 35,000 shares at $5.61 ($196,399)
- 4 Planned sale President & CEO sold 7,500 shares at $6.22 ($46,635)
- 4 Open-market sale Chief Medical Officer sold 7,412 shares at $5.86 ($43,437)
- 4 Open-market sale Chief Development Officer sold 7,219 shares at $5.86 ($42,306)
- 4 Open-market sale Chief Financial Officer sold 5,289 shares at $5.86 ($30,995)
- 4 Open-market sale President & CEO sold 32,225 shares at $5.86 ($188,848)
- 4 Open-market sale GRAMMER ELIZABETH A sold 7,089 shares at $5.86 ($41,544)
- 4 Open-market sale Felsch Robert Ora sold 3,567 shares at $5.86 ($20,904)
- 4 Open-market sale Blanks Robert sold 4,969 shares at $5.86 ($29,120)
- 4 Planned sale Chief Development Officer sold 40,507 shares at an average $5.97 ($241,782)
- 4 Grant or award Chief Commercial Officer acquired 180,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President & CEO sold 1,229 shares at $5.71 ($7,018)
- 4 Planned sale President & CEO sold 30,000 shares at $5.64 ($169,314)
- 4 Planned sale President & CEO sold 7,500 shares at $5.97 ($44,768)
- 4 Planned sale President & CEO sold 2,310 shares at $6.59 ($15,223)
Page 7 of 35 · 690 filings